Roxanne Nelson

News

Lymph2Cx assay identifies outcomes in DLBCL

Author:: Roxanne Nelson

Publish date: August 8, 2015

Key clinical point: The Lymph2Cx is an accurate assay for DLBCL cell of origin assignment, and identified groups with significantly different outc...

News

Docetaxel added to ADT extends survival from prostate cancer

Author:: Roxanne Nelson

Publish date: August 5, 2015

Key clinical point: Androgen deprivation therapy plus six cycles of docetaxel resulted in significantly longer overall survival compared with ADT ...

News

R-ISS identifies three survival patterns in multiple myeloma

Author:: Roxanne Nelson

Publish date: August 4, 2015

Key clinical point: The R-ISS staging system allows for improved risk stratification in newly diagnosed patients with multiple myeloma. Major find...

News

Anticoagulant therapy not contraindicated in brain metastases

Author:: Roxanne Nelson

Publish date: August 3, 2015

Treatment of venous thromboembolism with anticoagulation does not increase the risk of intracranial hemorrhage in cancer patients with metastasis to t...

News

ASCO guidelines define use of biomarkers for advanced breast cancer treatment

Author:: Roxanne Nelson

Publish date: July 30, 2015

New guidelines from the American Society of Clinical Oncology provide evidence based recommendations on the appropriate use of biomarkers in the treat...